Phathom Pharmaceuticals Statistics
Total Valuation
PHAT has a market cap or net worth of $886.49 million. The enterprise value is $1.35 billion.
Important Dates
The next estimated earnings date is Thursday, April 30, 2026, before market open.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PHAT has 78.80 million shares outstanding. The number of shares has increased by 15.42% in one year.
| Current Share Class | 78.80M |
| Shares Outstanding | 78.80M |
| Shares Change (YoY) | +15.42% |
| Shares Change (QoQ) | +0.57% |
| Owned by Insiders (%) | 3.68% |
| Owned by Institutions (%) | 51.79% |
| Float | 59.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.06 |
| Forward PS | 2.61 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.73
| Current Ratio | 1.73 |
| Quick Ratio | 1.58 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.35 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -31.37% |
| Return on Invested Capital (ROIC) | -44.21% |
| Return on Capital Employed (ROCE) | -125.87% |
| Weighted Average Cost of Capital (WACC) | 8.21% |
| Revenue Per Employee | $471,995 |
| Profits Per Employee | -$596,353 |
| Employee Count | 371 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 5.18 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +130.53% in the last 52 weeks. The beta is 0.61, so PHAT's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | +130.53% |
| 50-Day Moving Average | 11.83 |
| 200-Day Moving Average | 12.29 |
| Relative Strength Index (RSI) | 50.69 |
| Average Volume (20 Days) | 1,086,916 |
Short Selling Information
The latest short interest is 11.66 million, so 14.79% of the outstanding shares have been sold short.
| Short Interest | 11.66M |
| Short Previous Month | 11.17M |
| Short % of Shares Out | 14.79% |
| Short % of Float | 19.68% |
| Short Ratio (days to cover) | 12.16 |
Income Statement
In the last 12 months, PHAT had revenue of $175.11 million and -$221.25 million in losses. Loss per share was -$3.03.
| Revenue | 175.11M |
| Gross Profit | 152.51M |
| Operating Income | -159.99M |
| Pretax Income | -221.25M |
| Net Income | -221.25M |
| EBITDA | -159.35M |
| EBIT | -159.99M |
| Loss Per Share | -$3.03 |
Full Income StatementBalance Sheet
The company has $129.97 million in cash and $589.17 million in debt, with a net cash position of -$459.20 million or -$5.83 per share.
| Cash & Cash Equivalents | 129.97M |
| Total Debt | 589.17M |
| Net Cash | -459.20M |
| Net Cash Per Share | -$5.83 |
| Equity (Book Value) | -438.17M |
| Book Value Per Share | -6.14 |
| Working Capital | 96.93M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$166.78 million and capital expenditures -$229,000, giving a free cash flow of -$167.00 million.
| Operating Cash Flow | -166.78M |
| Capital Expenditures | -229,000 |
| Depreciation & Amortization | 633,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -167.00M |
| FCF Per Share | -$2.12 |
Full Cash Flow StatementMargins
Gross margin is 87.09%, with operating and profit margins of -91.36% and -126.35%.
| Gross Margin | 87.09% |
| Operating Margin | -91.36% |
| Pretax Margin | -126.35% |
| Profit Margin | -126.35% |
| EBITDA Margin | -91.00% |
| EBIT Margin | -91.36% |
| FCF Margin | n/a |
Dividends & Yields
PHAT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.42% |
| Shareholder Yield | -15.42% |
| Earnings Yield | -24.96% |
| FCF Yield | -18.84% |
Analyst Forecast
The average price target for PHAT is $19.83, which is 76.27% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.83 |
| Price Target Difference | 76.27% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 42.72% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PHAT has an Altman Z-Score of -8.38 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.38 |
| Piotroski F-Score | 3 |
